APA (7th ed.) Citation

Yang, M., Fan, Y., Wu, Z., Gu, J., Feng, Z., Zhang, Q., . . . Wang, K. (2021). DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations. EBioMedicine, 69, 103446. https://doi.org/10.1016/j.ebiom.2021.103446

Chicago Style (17th ed.) Citation

Yang, Mei, et al. "DAGM: A Novel Modelling Framework to Assess the Risk of HER2-negative Breast Cancer Based on Germline Rare Coding Mutations." EBioMedicine 69 (2021): 103446. https://doi.org/10.1016/j.ebiom.2021.103446.

MLA (9th ed.) Citation

Yang, Mei, et al. "DAGM: A Novel Modelling Framework to Assess the Risk of HER2-negative Breast Cancer Based on Germline Rare Coding Mutations." EBioMedicine, vol. 69, 2021, p. 103446, https://doi.org/10.1016/j.ebiom.2021.103446.